Immunization Newsbriefs (c) Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii's new website at http://www.immunizationinfo.org.
------------------------------------------------------------
February 28, 2003
U.S. IMMUNIZATION NEWS
"Chiron Sets Phase III Trial for Meningococcal C Vaccine"
Dow Jones Newswire (www.djnewswires.com) (02/27/03); Park, Jenny
Chiron Corp. plans to launch this year a phase III trial of its Menjugate vaccine in the United States. The conjugate vaccine to protect against meningococcal C disease has already been approved for use in infants through adults in 24 nations. Chiron noted that Neisseria meningitidis causes approximately 120,000 cases of bacterial meningitis and sepsis annually, with about 3,000 of those cases in the United States.
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.